OKYO Pharma annual current ratio
2021
2022
2023
2024
2025
2026
OKYO Pharma Current Ratio Growth & History (OKYO)
OKYO Pharma's current ratio was 2.43 for fiscal 2026.
View full OKYO Pharma company overviewOKYO Pharma annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | 2.43 | 2.03 | +509.24% |
| 2025 · Mar 31 | 2025-03-31 | 0.40 | 0.19 | +92.20% |
| 2024 | 2024-03-31 | 0.21 | −0.51 | −71.06% |
| 2023 | 2023-03-31 | 0.72 | −2.46 | −77.44% |
| 2022 | 2022-03-31 | 3.17 | −0.92 | −22.43% |
| 2021 | 2021-03-31 | 4.09 | — | — |
OKYO Pharma quarterly current ratio
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | 2.43 | 2.03 | +509.24% |
| Q2 2026 | 2025-09-30 | 0.58 | — | — |
| Q4 2025 | 2025-03-31 | 0.40 | 0.19 | +92.20% |
| Q4 2024 | 2024-03-31 | 0.21 | −0.51 | −71.06% |
| Q4 2023 | 2023-03-31 | 0.72 | −2.46 | −77.44% |
| Q4 2022 | 2022-03-31 | 3.17 | −0.92 | −22.43% |
| Q4 2021 | 2021-03-31 | 4.09 | — | — |
OKYO Pharma current ratio trends
Over the last five fiscal years, OKYO Pharma's current ratio decreased from 4.09 to 2.43, a change of −1.67. The latest reported quarter, Q4 2026, shows 2.43.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OKYO Pharma source filings ↗